Skip to main content

Table 1 Baseline characteristics of study participants

From: Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial

Characteristics AS + DP N = 79 AS + AL N = 71
Female (%) 36 (45.6) 36 (50.7)
Age in months* 17 (11–26) 16 (10–26)
Weight (kg)* 9.5 (8–11.5) 9 (8.1–11)
Temperature (°C)* 38.8 (37.7–39.5) 39.1 (37.7–39.5)
Parasite density per μL, log10 copies* 4.82 (4.29–5.10) 4.79 (4.38–5.02)
Haemoglobin (mg/dL)* 9.1 (7.9–10.5) 9.2 (8.4–10.6)
Total white blood cell count (*103/μL)* 9.6 (6.9–13.2) 9.2 (7.5–12.3)
Random blood sugar (mmol/L)* 7.3 (6.3–8.3) 6.8 (6.4–8.3)
Complications at admission, n (%)
 Patients with history of repeated convulsions n (%) 6 (7.6%) 3 (4.2%)
 Patients with history of inability to feed 26 (33.0%) 24 (34.0%)
 Patients with prostration (extreme weakness) 22 (27.9%) 15 (21.13%)
 Haemoglobinuria 0 0
 Jaundice 2 (2.5%) 0
 Severe anaemia 0 0
 Respiratory distress 2 (2.5%) 6 (8.5%)
 Impaired consciousness 0 0
 Abnormal bleeding 2 (2.5%) 1 (1.4%)
 Hypoglycaemia 0 0
  1. * Values are presented as medians (IQR)